| The consensus molecular subtypes of colorectal cancer J Guinney, R Dienstmann, X Wang, A De Reynies, A Schlicker, ... Nature medicine 21 (11), 1350-1356, 2015 | 4239 | 2015 |
| Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy EA Collisson, A Sadanandam, P Olson, WJ Gibb, M Truitt, S Gu, J Cooc, ... Nature medicine 17 (4), 500-503, 2011 | 1652 | 2011 |
| Patient-derived organoids model treatment response of metastatic gastrointestinal cancers G Vlachogiannis, S Hedayat, A Vatsiou, Y Jamin, J Fernández-Mateos, ... Science 359 (6378), 920-926, 2018 | 1367 | 2018 |
| A colorectal cancer classification system that associates cellular phenotype and responses to therapy A Sadanandam, CA Lyssiotis, K Homicsko, EA Collisson, WJ Gibb, ... Nature medicine 19 (5), 619-625, 2013 | 1049 | 2013 |
| Yap1 activation enables bypass of oncogenic Kras addiction in pancreatic cancer A Kapoor, W Yao, H Ying, S Hua, A Liewen, Q Wang, Y Zhong, CJ Wu, ... Cell 158 (1), 185-197, 2014 | 659 | 2014 |
| Subtype and pathway specific responses to anticancer compounds in breast cancer LM Heiser, A Sadanandam, WL Kuo, SC Benz, TC Goldstein, S Ng, ... Proceedings of the National Academy of Sciences 109 (8), 2724-2729, 2012 | 526 | 2012 |
| Inter‐and intra‐tumoural heterogeneity in cancer‐associated fibroblasts of human pancreatic ductal adenocarcinoma C Neuzillet, A Tijeras‐Raballand, C Ragulan, J Cros, Y Patil, M Martinet, ... The Journal of pathology 248 (1), 51-65, 2019 | 243 | 2019 |
| Chemokines in tumor angiogenesis and metastasis S Singh, A Sadanandam, RK Singh Cancer and Metastasis Reviews 26, 453-467, 2007 | 224 | 2007 |
| Genomic and transcriptomic determinants of therapy resistance and immune landscape evolution during anti-EGFR treatment in colorectal cancer A Woolston, K Khan, G Spain, LJ Barber, B Griffiths, R Gonzalez-Exposito, ... Cancer cell 36 (1), 35-50. e9, 2019 | 189 | 2019 |
| Small-molecule antagonists for CXCR2 and CXCR1 inhibit human melanoma growth by decreasing tumor cell proliferation, survival, and angiogenesis S Singh, A Sadanandam, KC Nannuru, ML Varney, R Mayer-Ezell, ... Clinical Cancer Research 15 (7), 2380-2386, 2009 | 169 | 2009 |
| A cross-species analysis in pancreatic neuroendocrine tumors reveals molecular subtypes with distinctive clinical, metastatic, developmental, and metabolic characteristics A Sadanandam, S Wullschleger, CA Lyssiotis, C Grötzinger, S Barbi, ... Cancer discovery 5 (12), 1296-1313, 2015 | 156 | 2015 |
| The expression level of HJURP has an independent prognostic impact and predicts the sensitivity to radiotherapy in breast cancer Z Hu, G Huang, A Sadanandam, S Gu, ME Lenburg, M Pai, N Bayani, ... Breast cancer research 12, 1-15, 2010 | 154 | 2010 |
| ATR inhibition potentiates the radiation-induced inflammatory tumor microenvironment MT Dillon, KF Bergerhoff, M Pedersen, H Whittock, E Crespo-Rodriguez, ... Clinical Cancer Research 25 (11), 3392-3403, 2019 | 145 | 2019 |
| CXCR1 and CXCR2 enhances human melanoma tumourigenesis, growth and invasion S Singh, KC Nannuru, A Sadanandam, ML Varney, RK Singh British journal of cancer 100 (10), 1638-1646, 2009 | 143 | 2009 |
| Molecular subtypes in cancers of the gastrointestinal tract MF Bijlsma, A Sadanandam, P Tan, L Vermeulen Nature reviews Gastroenterology & hepatology 14 (6), 333-342, 2017 | 119 | 2017 |
| Semaphorin 5A promotes angiogenesis by increasing endothelial cell proliferation, migration, and decreasing apoptosis A Sadanandam, EG Rosenbaugh, S Singh, M Varney, RK Singh Microvascular research 79 (1), 1-9, 2010 | 116 | 2010 |
| Context matters—consensus molecular subtypes of colorectal cancer as biomarkers for clinical trials E Fontana, K Eason, A Cervantes, R Salazar, A Sadanandam Annals of Oncology 30 (4), 520-527, 2019 | 109 | 2019 |
| Cathepsin G Enhances Mammary Tumor–Induced Osteolysis by Generating Soluble Receptor Activator of Nuclear Factor-κb Ligand TJ Wilson, KC Nannuru, M Futakuchi, A Sadanandam, RK Singh Cancer research 68 (14), 5803-5811, 2008 | 99 | 2008 |
| Reconciliation of classification systems defining molecular subtypes of colorectal cancer: interrelationships and clinical implications A Sadanandam, X Wang, F de Sousa E Melo, JW Gray, L Vermeulen, ... Cell cycle 13 (3), 353-357, 2014 | 96 | 2014 |
| A rectal cancer feasibility study with an embedded phase III trial design assessing magnetic resonance tumour regression grade (mrTRG) as a novel biomarker to stratify … NJ Battersby, M Dattani, S Rao, D Cunningham, D Tait, R Adams, ... Trials 18 (1), 1-14, 2017 | 87 | 2017 |
Joe GrayBiomedical Engineering, Oregon Health and Science UniversityVerified email at ohsu.edu
